Bioceres Crop Solutions (BIOX) EBITDA (2016 - 2026)

Bioceres Crop Solutions has disclosed EBITDA across 11 years of filings, most recently posting -$9.7 million for Q1 2026.

• EBITDA for Q1 2026 came in at -$9.7 million, down 304.17% year-over-year; the trailing twelve-month figure through Mar 2026 was -$232.1 million (down 2341.05% YoY), and the FY2025 annual result was -$55.9 million, down 960.0% from the prior year.
• EBITDA came in at -$9.7 million for Q1 2026 at Bioceres Crop Solutions, up from -$182.2 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $27.4 million in Q1 2023 to a low of -$182.2 million in Q4 2025.
• The 5-year median for EBITDA is $699245.0 (2024), against an average of -$11.6 million.
• Across the five-year window, EBITDA jumped 408.56% in 2023 and sank 26156.81% in 2025, its largest moves.
• Bioceres Crop Solutions' EBITDA stood at -$7.8 million in 2022, then surged by 121.99% to $1.7 million in 2023, then plunged by 59.45% to $699245.0 in 2024, then tumbled by 26156.81% to -$182.2 million in 2025, then surged by 94.68% to -$9.7 million in 2026.
• The last three EBITDA figures came in at -$9.7 million (Q1 2026), -$182.2 million (Q4 2025), and $7.8 million (Q3 2025), per Business Quant data.